Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model

Despite increasingly successful treatment of pediatric ALL, up to 20% of patients encounter relapse. By current biomarkers, the majority of relapse patients is initially not identified indicating the need for prognostic and therapeutic targets reflecting leukemia biology. We previously described tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan, Md. Nabiul, Queudeville, Manon, Trentin, Luca, Eckhoff, Sarah Mirjam, Bronzini, Ilaria, Palmi, Chiara, Barth, Thomas, Cazzaniga, Giovanni, te Kronnie, Geertruy, Debatin, Klaus-Michael, Meyer, Lüder Hinrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359301/
https://www.ncbi.nlm.nih.gov/pubmed/25682198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359301/
https://www.ncbi.nlm.nih.gov/pubmed/25682198

Ejemplares similares